TG Therapeutics, Inc. (NASDAQ: TGTX), Morrisville, NC – FDA Inspections
Inspection records and compliance data for TG Therapeutics, Inc. in Morrisville, North Carolina. 3 FDA inspections on record, last inspected July 16, 2026. Publicly traded as NASDAQ: TGTX.
This profile covers TG Therapeutics, Inc. based in Morrisville, North Carolina, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected August 18, 2020. Last inspected July 16, 2026.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 16, 2026 | Not classified | Human Drugs | 1328816 |
| January 29, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1135591 |
| August 18, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1128550 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
TG Therapeutics, Inc.
Stock ticker
TGTX
Exchange
NASDAQ
Share price
$57.98
Market cap
$8.9B
Price as of
November 6, 2026
FEI Number
3016405037
Address
3020 Carrington Mill Blvd, Suite 475, Morrisville, North Carolina 27560, United States
Country
United States
ID: 3cfc4859-c527-4e7f-999f-b89852a9b1ec